
Sign up to save your podcasts
Or


Have you been living with debilitating hot flashes, sleepless nights, or painful intercourse because you're terrified hormone therapy will give you cancer? What if everything you've been told about menopause treatment has been wrong?
In this urgent episode of Pleasure In the Pause, host Gabriela Espinosa reveals a seismic shift in women's healthcare: the FDA has just eliminated the fear-based black box warnings that have kept millions of women from accessing hormone therapy for over two decades. This isn't just a policy change—it's a complete vindication of the science that's been buried under misinformation since 2002.
Highlights from our discussion include:
The era of dismissing, minimizing, and scaring women away from effective treatment is over.
This FDA decision represents more than regulatory housekeeping—it's a fundamental shift in how women's health is valued and treated. But knowing your options exist is only the first step. Now it's time to advocate for yourself. Every woman who hears this information is one step closer to reclaiming her health, her comfort, and her power. The grassroots advocacy that made this FDA decision possible—including the 26,000+ signatures collected by Let's Talk Menopause—proves that our voices matter.
If you're seeking to reclaim your pleasure and vitality, join Gabriella at www.pleasureinthepause.com for this enlightening journey into the heart of female pleasure and empowerment.
LINKS MENTIONED:
Ep 34 with Jill Chmielewski
FDA Press Conference
CONNECT WITH GABRIELLA ESPINOSA:
Work with Gabriella!
Full episodes on YouTube.
The information shared on Pleasure in the Pause is for educational and informational purposes only and is not intended as medical advice. Always consult your healthcare provider before making any decisions about your health or treatment. The views expressed by guests are their own and do not necessarily reflect the views of the host or Pleasure in the Pause.
By Gabriella Espinosa4
88 ratings
Have you been living with debilitating hot flashes, sleepless nights, or painful intercourse because you're terrified hormone therapy will give you cancer? What if everything you've been told about menopause treatment has been wrong?
In this urgent episode of Pleasure In the Pause, host Gabriela Espinosa reveals a seismic shift in women's healthcare: the FDA has just eliminated the fear-based black box warnings that have kept millions of women from accessing hormone therapy for over two decades. This isn't just a policy change—it's a complete vindication of the science that's been buried under misinformation since 2002.
Highlights from our discussion include:
The era of dismissing, minimizing, and scaring women away from effective treatment is over.
This FDA decision represents more than regulatory housekeeping—it's a fundamental shift in how women's health is valued and treated. But knowing your options exist is only the first step. Now it's time to advocate for yourself. Every woman who hears this information is one step closer to reclaiming her health, her comfort, and her power. The grassroots advocacy that made this FDA decision possible—including the 26,000+ signatures collected by Let's Talk Menopause—proves that our voices matter.
If you're seeking to reclaim your pleasure and vitality, join Gabriella at www.pleasureinthepause.com for this enlightening journey into the heart of female pleasure and empowerment.
LINKS MENTIONED:
Ep 34 with Jill Chmielewski
FDA Press Conference
CONNECT WITH GABRIELLA ESPINOSA:
Work with Gabriella!
Full episodes on YouTube.
The information shared on Pleasure in the Pause is for educational and informational purposes only and is not intended as medical advice. Always consult your healthcare provider before making any decisions about your health or treatment. The views expressed by guests are their own and do not necessarily reflect the views of the host or Pleasure in the Pause.

1,965 Listeners

112,880 Listeners

5,130 Listeners

998 Listeners

2,635 Listeners

3,499 Listeners

255 Listeners

87 Listeners

1,079 Listeners

39 Listeners

525 Listeners

41,597 Listeners

344 Listeners

20,061 Listeners

115 Listeners